These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 3071345)
1. Human recombinant granulocyte macrophage colony stimulating factor (GM-CSF) treatment of patients with acute leukemias in aplasia and at high risk of early death. Büchner T; Hiddemann W; Zühlsdorf M; Koenigsmann M; Böckmann A; van de Loo J; Schulz G Behring Inst Mitt; 1988 Aug; (83):309-12. PubMed ID: 3071345 [TBL] [Abstract][Full Text] [Related]
2. Recombinant human GM-CSF following chemotherapy in high-risk AML. Buechner T; Hiddemann W; Koenigsmann M; Zuehlsdorf M; Woermann B; Boeckmann A; Aguion Freire E; Innig G; Maschmeyer G; Ludwig WD Bone Marrow Transplant; 1990 Jul; 6 Suppl 1():131-4. PubMed ID: 2202465 [TBL] [Abstract][Full Text] [Related]
3. Effect of granulocyte colony-stimulating factor after intensive induction therapy in relapsed or refractory acute leukemia. Ohno R; Tomonaga M; Kobayashi T; Kanamaru A; Shirakawa S; Masaoka T; Omine M; Oh H; Nomura T; Sakai Y N Engl J Med; 1990 Sep; 323(13):871-7. PubMed ID: 1697646 [TBL] [Abstract][Full Text] [Related]
4. Use of granulocyte-macrophage colony-stimulating factor in patients with malignancy and bone marrow failure. Shadduck RK; Rosenfeld CS; Sulecki M; Phillips N; Przepiorka D; Earle M; Stoller R; Jacobs S Int J Cell Cloning; 1990 Jan; 8 Suppl 1():303-12; discussion 312-3. PubMed ID: 2182742 [TBL] [Abstract][Full Text] [Related]
5. G-CSF is a major component of colony-stimulating activity (CSA) in the plasma of patients with multiple myeloma after treatment with high-dose melphalan (HDM). Joffe JK; Bell JB; Denham S; Adshead F; Millar JL; Millar BC Exp Hematol; 1995 Apr; 23(4):376-82. PubMed ID: 7534716 [TBL] [Abstract][Full Text] [Related]
6. Growth characteristics of marrow hematopoietic progenitor/precursor cells from patients on a phase I clinical trial with purified recombinant human granulocyte-macrophage colony-stimulating factor. Broxmeyer HE; Cooper S; Williams DE; Hangoc G; Gutterman JU; Vadhan-Raj S Exp Hematol; 1988 Aug; 16(7):594-602. PubMed ID: 3260558 [TBL] [Abstract][Full Text] [Related]
7. New perspectives in the treatment of acute myeloid leukemia by hematopoietic growth factors. Hiddemann W; Wörmann B; Reuter C; Schleyer E; Zühlsdorf M; Böckmann A; Büchner T Semin Oncol; 1994 Dec; 21(6 Suppl 16):33-8. PubMed ID: 7528449 [TBL] [Abstract][Full Text] [Related]
8. Hematopoietic growth factors in patients receiving intensive chemotherapy for malignant disorders: studies of granulocyte-colony stimulating factor (G-CSF), granulocyte-macrophage colony stimulating factor (GM-CSF), interleukin-3 (IL-3) and Flt-3 ligand (Flt3L). Bruserud O; Foss B; Petersen H Eur Cytokine Netw; 2001; 12(2):231-8. PubMed ID: 11399510 [TBL] [Abstract][Full Text] [Related]
10. Recovery from severe hematopoietic suppression using recombinant human granulocyte-macrophage colony-stimulating factor. Monroy RL; Skelly RR; Taylor P; Dubois A; Donahue RE; MacVittie TJ Exp Hematol; 1988 Jun; 16(5):344-8. PubMed ID: 3286278 [TBL] [Abstract][Full Text] [Related]
11. Phase I study of recombinant DNA granulocyte macrophage colony stimulating factor. Steward WP; Scarffe JH; Austin R; Crowther D Behring Inst Mitt; 1988 Aug; (83):324-6. PubMed ID: 3071348 [TBL] [Abstract][Full Text] [Related]
12. A phase I study of therapy with recombinant granulocyte-macrophage colony-stimulating factor administered by IV bolus or continuous infusion. Rifkin RM; Hersh EM; Salmon SE Behring Inst Mitt; 1988 Aug; (83):125-33. PubMed ID: 3071327 [TBL] [Abstract][Full Text] [Related]
13. Granulocytic colony-stimulating factors (G-CSF and GM-CSF) in the treatment of adult acute myeloid leukemia. Dombret H; Toubert ME; Schlageter MH; Chomienne C; Degos L Nouv Rev Fr Hematol (1978); 1991; 33(6):445-8. PubMed ID: 1726333 [TBL] [Abstract][Full Text] [Related]
14. Changing response of clonogenic myeloid leukemia blasts to granulocyte-macrophage colony-stimulating factor (GM-CSF) during anti-leukemic therapy--a case report on the basis of a clinical phase II trial. Hiddemann W; Zühlsdorf M; Wörmann B; Koenigsmann M; Büchner T Leuk Res; 1990; 14(4):347-52. PubMed ID: 2185381 [TBL] [Abstract][Full Text] [Related]
15. Clinical studies with recombinant human granulocyte-macrophage colony-stimulating factor. Steward WP; Scarffe JH; Bonnem E; Crowther D Int J Cell Cloning; 1990 Jan; 8 Suppl 1():335-46. PubMed ID: 2182743 [TBL] [Abstract][Full Text] [Related]
16. The clinical use of hematopoietic growth factors. Appelbaum FR Semin Hematol; 1989 Jul; 26(3 Suppl 3):7-14. PubMed ID: 2477905 [TBL] [Abstract][Full Text] [Related]
17. Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma. Arora M; Burns LJ; Barker JN; Miller JS; Defor TE; Olujohungbe AB; Weisdorf DJ Biol Blood Marrow Transplant; 2004 Jun; 10(6):395-404. PubMed ID: 15148493 [TBL] [Abstract][Full Text] [Related]
18. Effects of CSFs in preleukemia. Greenberg PL; Negrin R; Nagler A Bone Marrow Transplant; 1990 Jul; 6 Suppl 1():121-6. PubMed ID: 1697191 [TBL] [Abstract][Full Text] [Related]
19. Recombinant human granulocyte-macrophage colony stimulating factor (rh GM-CSF) after bone marrow transplantation. Link H; Freund M; Kirchner H; Stoll M; Schmid H; Bucsky P; Seidel J; Schulz G; Schmidt RE; Riehm H Behring Inst Mitt; 1988 Aug; (83):313-9. PubMed ID: 3071346 [TBL] [Abstract][Full Text] [Related]
20. Potential role of granulocyte-macrophage colony stimulating factor in patients with HIV infection. Mitsuyasu RT; Golde DW Behring Inst Mitt; 1988 Aug; (83):139-44. PubMed ID: 3071329 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]